Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

This study has been completed.

Study NCT00014287 Information provided by National Cancer Institute (NCI)

First Received: April 10, 2001 Last Updated: December 26, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given